Analysis of Hirsutism as a Symptom of Amenorrhea and Its Relation to Polycystic Ovary Syndrome

    April 2025 in “ PubMed ”
    Sabba Saltanat, Nadeem Ahmad, Samer Sayyed, Wasim Ahmad, Zebaakhter R Sayyed, Fauzia Shahabuddin
    TLDR Hirsutism in women is linked to PCOS and can cause health issues if untreated.
    This study examines hirsutism, characterized by excessive hair growth in females, as a symptom of amenorrhea and its link to polycystic ovary syndrome (PCOS) from both Unani and modern medical perspectives. Unani scholars historically associated hirsutism with menstrual irregularities, suggesting that retained menstrual blood transforms into vapors that manifest as hair. Modern medicine attributes hirsutism to hyperandrogenism, often seen in PCOS. The study reviews Unani texts and modern research, highlighting that untreated hirsutism and amenorrhea can lead to metabolic and reproductive issues. It suggests that herbs like Juniperus communis and Zingiber officinale may help regulate menstrual cycles. The findings underscore the need for integrative research to improve diagnostic and therapeutic strategies for hirsutism.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 26 results

      community AA and Hirsutism but T levels are normal

      in Female  6 upvotes 4 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community Finasteride 5mg & Spironolactone 100mg

      in Female  2 upvotes 5 months ago
      A 20-year-old female is using finasteride 5mg and spironolactone 100mg for severe hirsutism and is experiencing minor side effects like water weight loss and irregular periods. She is concerned about potential future side effects and hair regrowth on her scalp.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 4 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  120 upvotes 8 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Does low HGH leading to hairloss?

      in Research/Science  11 upvotes 1 year ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

    Related Research

    3 / 3 results